Luteolin-7-O-β-d-Glucuronide Attenuated Cerebral Ischemia/Reperfusion Injury: Involvement of the Blood–Brain Barrier
Open Access
- 19 June 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (6) , 1366
Abstract
Ischemic stroke is a common cerebrovascular disease with high mortality, high morbidity, and high disability. Cerebral ischemia/reperfusion injury seriously affects the quality of life of patients. Luteolin-7-O-β-d-glucuronide (LGU) is a major active flavonoid compound extracted from Ixeris sonchifolia (Bge.) Hance, a Chinese medicinal herb mainly used for the treatment of coronary heart disease, angina pectoris, cerebral infarction, etc. In the present study, the protective effect of LGU on cerebral ischemia/reperfusion injury was investigated in an oxygen–glucose deprivation/reoxygenation (OGD/R) neuronal model and a transient middle cerebral artery occlusion (tMCAO) rat model. In in vitro experiments, LGU was found to improve the OGD/R-induced decrease in neuronal viability effectively by the MTT assay. In in vivo experiments, neurological deficit scores, infarction volume rates, and brain water content rates were improved after a single intravenous administration of LGU. These findings suggest that LGU has significant protective effects on cerebral ischemia/reperfusion injury in vitro and in vivo. To further explore the potential mechanism of LGU on cerebral ischemia/reperfusion injury, we performed a series of tests. The results showed that a single administration of LGU decreased the content of EB and S100B and ameliorated the abnormal expression of tight junction proteins ZO-1 and occludin and metalloproteinase MMP-9 in the ischemic cerebral cortex of the tMCAO 24-h injury model. In addition, LGU also improved the tight junction structure between endothelial cells and the degree of basement membrane degradation and reduced the content of TNF-α and IL-1β in the brain tissue. Thereby, LGU attenuated cerebral ischemia/reperfusion injury by improving the permeability of the blood–brain barrier. The present study provides new insights into the therapeutic potential of LGU in cerebral ischemia.Keywords
Funding Information
- Liaoning Provincial Livelihood Science and Technology Plan Project (2021JH2/10300073, JYTMS20231379)
- Scientific Research Project of the Education Department of Liaoning Province (2021JH2/10300073, JYTMS20231379)
This publication has 45 references indexed in Scilit:
- Using Evans Blue Dye to Determine Blood‐Brain Barrier Integrity in RodentsCurrent Protocols in Immunology, 2019
- Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitroMetabolic Brain Disease, 2017
- Anti-Inflammatory Effect of Apigenin on LPS-Induced Pro-Inflammatory Mediators and AP-1 Factors in Human Lung Epithelial CellsInflammation, 2015
- Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆Advanced Drug Delivery Reviews, 2009
- Adherens and tight junctions: Structure, function and connections to the actin cytoskeletonBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- TNF-α in promotion and progression of cancerCancer and Metastasis Reviews, 2006
- Occludin: Structure, function and regulationAdvanced Drug Delivery Reviews, 2005
- Serum S100βCancer, 2003
- Pathophysiology of ischaemia-reperfusion injuryThe Journal of Pathology, 2000
- In vitro evaluation of cell/biomaterial interaction by MTT assayBiomaterials, 1993